Romiplostim - Amgen
At a glance
- Drug Originator Kirin-Amgen
- Drug Licenced by Amgen; Clinigen; Tecnofarma International
- Drug Class Antianaemics; Carrier proteins; Immunotherapies; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Thrombopoietin receptor agonists
- USA Patent Applicants AMGEN
- USA Patents 43
- BLAs 1
- International Patents 529
Disclaimer